Pharmacological interventions to reduce platinum-induced toxicity.
Tognella
S
S
Research Center, Boehringer Mannheim Italia, Monza, Milan, Italy.
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D004999:Amifostine / Q000627:therapeutic use; D002945:Cisplatin / Q000009:adverse effects*; D004050:Ditiocarb / Q000627:therapeutic use; D005440:Fluid Therapy; D005978:Glutathione / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control; D009422:Nervous System Diseases / Q000139:chemically induced / Q000517:prevention & control; D010446:Peptide Fragments / Q000627:therapeutic use; D013885:Thiosulfates / Q000627:therapeutic use
D010446:Peptide Fragments; D013885:Thiosulfates; C013765:Org 2766; D000324:Adrenocorticotropic Hormone; D004050:Ditiocarb; D005978:Glutathione; D004999:Amifostine; D002945:Cisplatin